Tirosint
NDC 71858-0005, levothyroxine sodium, capsule, from IBSA Pharma Inc..
- Product NDC
- 71858-0005
- Status
- Listed
- Labeler
- IBSA Pharma Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021924
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71858-0005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOTHYROXINE SODIUM13 ug/1
Pharmacologic classes
Thyroxine [CS]; l-Thyroxine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71858-0005-2 | 71858000502 | 3 BLISTER PACK in 1 CARTON (71858-0005-2) / 10 CAPSULE in 1 BLISTER PACK |
| 71858-0005-4 | 71858000504 | 3 BLISTER PACK in 1 CARTON (71858-0005-4) / 10 CAPSULE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/7a7ade79-0165-4e31-b84e-667416c00c7e
Use it
Look up 71858-0005 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71858-0005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71858-0005. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.